Inactive Instrument
Sector Relmada Therapeutics Inc OTC Bulletin Board
Stocks
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 06-29 | Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to Russell Small Cap Comp Growth Benchmark | CI |
| 06-29 | Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to Russell 2500 Growth Benchmark | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.43% | -4.26% | +17.85% | +26.85% | +38.90% | +52.09% | +85.69% | -22.26% | - | 55.27B | |
| -0.24% | +1.04% | -4.72% | +11.79% | +5.80% | +55.76% | +54.21% | +179.34% | +5,742.84% | 54.15B | |
| -1.82% | -2.89% | +8.15% | -26.19% | -38.73% | +3.61% | +405.88% | +326.22% | +864.20% | 23.11B | |
| -0.54% | -0.17% | +1.82% | -15.44% | -3.54% | -17.60% | -15.43% | -67.32% | - | 23.22B | |
| +1.03% | -0.20% | +26.01% | +15.68% | +24.81% | +36.49% | -3.23% | -69.75% | - | 20.33B | |
| +3.16% | +0.79% | +15.43% | +7.63% | -5.72% | +37.98% | -31.36% | -31.73% | +66.46% | 17.91B | |
| +1.45% | +0.19% | +31.53% | +12.68% | +33.48% | +39.60% | +556.02% | - | - | 15.76B | |
| +0.43% | -10.61% | +19.54% | +102.31% | +178.50% | +175.63% | +299.61% | +1,558.20% | +629.94% | 15B | |
| -2.03% | -1.03% | +7.07% | +17.35% | +25.44% | +23.63% | +179.23% | +224.56% | +533.41% | 13.82B | |
| -1.67% | -2.29% | +4.83% | +1.61% | -7.67% | +71.55% | +149.20% | +491.34% | - | 12.4B | |
| +0.75% | -2.19% | +3.22% | -40.03% | -15.72% | -44.46% | +637.00% | +85.88% | +106.15% | 11.44B | |
| +6.17% | +3.05% | +22.69% | -19.56% | -7.17% | -26.85% | +172.11% | +98.11% | - | 11.62B | |
| +1.33% | -0.52% | +3.81% | +24.06% | +29.35% | +118.01% | +151.19% | +173.06% | +734.42% | 11.16B | |
| +19.03% | +23.50% | +8.17% | +19.99% | +33.60% | +492.91% | +145.84% | +30.59% | +1,469.91% | 12.49B | |
| -3.44% | -2.84% | -1.15% | +35.85% | +202.72% | +501.39% | +568.71% | -39.90% | -14.69% | 8.72B | |
| +2.33% | +3.29% | +31.34% | -16.14% | +21.94% | +32.03% | +97.53% | -8.11% | - | 8.9B | |
| -0.21% | -0.21% | +136.63% | +114.12% | +79.85% | +174.76% | +347.46% | +325.41% | - | 8.83B | |
| -1.34% | +4.62% | +53.47% | +34.19% | +25.99% | +36.69% | +365.81% | +347.09% | - | 8.72B | |
| -6.94% | -2.85% | +4.02% | -6.94% | +279.29% | +177.12% | +167.26% | -32.71% | - | 7.87B | |
| Average | +1.27% | -0.06% | +20.51% | +15.78% | +47.43% | +102.12% | +228.04% | +198.22% | +1,125.85% | 17.93B | |
| Weighted average by Cap. | +0.81% | -0.20% | +15.06% | +14.27% | +32.07% | +76.41% | +175.65% | +168.31% | +2,244.26% |
- Stock Market
- Stocks
- RLMD Stock
- Stock
- Sector Relmada Therapeutics Inc
Select your edition
All financial news and data tailored to specific country editions
